报价延迟最少15分钟:2025/09/17 22:34 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
126.72 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
4.28/6.04
|
|
企业价值
39.40B
|
| 资产负债 |
|
每股账面净值
22.47
|
| 现金流量 |
|
现金流量率
0.04
|
| 损益表 |
|
收益
6.51B
|
|
每股收益
24.67
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/09/17 22:34 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations. |
